Lei Wei
Impact in
- Immunology top 5%
- interferon and immune responses
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Epigenetics and DNA Methylation 3
- Renal and related cancers 2
-
- Cancer Genomics and Diagnostics 8
- Co-authors
- Yao Xu (1 shared paper)James J. Moon (1 shared paper)Xiaoyue Shi (1 shared paper)Yu Zhang (1 shared paper)Kyong Soo Park (1 shared paper)Xingwu Zhou (1 shared paper)Kai Han (1 shared paper)Jiaqian Li (1 shared paper)
- Journals
- Oncotarget (5 papers)Blood (3 papers)BMC Bioinformatics (2 papers)Cancers (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesChinaSpain
In The Last Decade
Lei Wei
52 papers receiving 1.9k citations
Lei Wei's Hit Papers
Peers
Comparison fields: 5 of 108
- Immunology 467
- Cancer Research 247
- Obstetrics and Gynecology 95
- Dermatology 114
- Biotechnology 107
Countries citing papers authored by Lei Wei
This map shows the geographic impact of Lei Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Wei more than expected).
Fields of papers citing papers by Lei Wei
This network shows the impact of papers produced by Lei Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Wei. The network helps show where Lei Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Amplifying STING activation by cyclic dinucleotide–manganese particles for local and systemic cancer metalloimmunotherapy Hit paper breakdown → | 2021 | 635 |
| 2 | 2012 | 181 | |
| 3 | 2016 | 163 | |
| 4 | 2016 | 155 | |
| 5 | 2021 | 135 | |
| 6 | 2015 | 54 | |
| 7 | 2016 | 47 | |
| 8 | 2018 | 43 | |
| 9 | 2016 | 37 | |
| 10 | 2014 | 36 | |
| 11 | 2021 | 35 | |
| 12 | 2013 | 29 | |
| 13 | 2017 | 29 | |
| 14 | 2005 | 28 | |
| 15 | 2021 | 27 | |
| 16 | 2018 | 27 | |
| 17 | 2018 | 26 | |
| 18 | 2015 | 26 | |
| 19 | 2015 | 23 | |
| 20 | 2015 | 20 |
About Lei Wei
Lei Wei is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Oncology, having authored 54 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Glycosylation and Glycoproteins Research (3 papers), Epigenetics and DNA Methylation (3 papers), Skin Protection and Aging (3 papers), Renal and related cancers (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Cancer Cells and Metastasis (2 papers) and Carbohydrate Chemistry and Synthesis (2 papers). The work is most often cited by research in Immunology (467 citations), Cancer Research (247 citations), Obstetrics and Gynecology (95 citations), Dermatology (114 citations) and Biotechnology (107 citations). Lei Wei has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Yao Xu, James J. Moon, Xiaoyue Shi, Yu Zhang, Kyong Soo Park, Xingwu Zhou, Kai Han, Jiaqian Li, Xiaoqi Sun and Jutaek Nam. Their work appears in journals such as Oncotarget, Blood, BMC Bioinformatics, Cancers and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.